DONGSUNG CHEMICAL Past Earnings Performance
Past criteria checks 2/6
DONGSUNG CHEMICAL has been growing earnings at an average annual rate of 52.5%, while the Chemicals industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 7.9% per year. DONGSUNG CHEMICAL's return on equity is 11.2%, and it has net margins of 3%.
Key information
52.5%
Earnings growth rate
51.0%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | 7.9% |
| Return on equity | 11.2% |
| Net Margin | 3.0% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Does DONGSUNG CHEMICAL (KRX:102260) Have A Healthy Balance Sheet?
Mar 25
Should You Buy Dongsung Corporation (KRX:102260) For Its 3.6% Dividend?
Mar 29Dongsung (KRX:102260) Seems To Use Debt Quite Sensibly
Mar 11What Type Of Shareholders Make Up Dongsung Corporation's (KRX:102260) Share Registry?
Feb 18What Type Of Returns Would Dongsung's(KRX:102260) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 31Our Take On The Returns On Capital At Dongsung (KRX:102260)
Jan 13
Just Three Days Till Dongsung Corporation (KRX:102260) Will Be Trading Ex-Dividend
Dec 24Would Dongsung Corporation (KRX:102260) Be Valuable To Income Investors?
Dec 14Should You Use Dongsung's (KRX:102260) Statutory Earnings To Analyse It?
Nov 26Revenue & Expenses BreakdownBeta
How DONGSUNG CHEMICAL makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,117,999 | 33,454 | 86,192 | 2,634 |
| 30 Sep 23 | 1,140,419 | 46,142 | 78,146 | 2,286 |
| 30 Jun 23 | 1,143,600 | 39,397 | 77,792 | 2,302 |
| 31 Mar 23 | 1,144,500 | 42,201 | 78,641 | 2,386 |
| 31 Dec 22 | 1,140,124 | 35,041 | 80,581 | 2,285 |
| 30 Sep 22 | 1,104,602 | 23,332 | 88,620 | 2,321 |
| 30 Jun 22 | 1,037,659 | 20,624 | 88,480 | 2,153 |
| 31 Mar 22 | 957,254 | 13,349 | 86,253 | 1,842 |
| 31 Dec 21 | 925,979 | 16,961 | 84,398 | 1,793 |
| 30 Sep 21 | 873,561 | 11,250 | 83,365 | 963 |
| 30 Jun 21 | 885,193 | 11,593 | 86,240 | 1,010 |
| 31 Mar 21 | 879,469 | 12,496 | 86,834 | 1,744 |
| 31 Dec 20 | 864,010 | 13,689 | 88,976 | 1,625 |
| 30 Sep 20 | 884,567 | 11,404 | 91,109 | 3,288 |
| 30 Jun 20 | 880,578 | 9,730 | 87,660 | 3,189 |
| 31 Mar 20 | 877,056 | 7,673 | 87,278 | 2,383 |
| 31 Dec 19 | 849,786 | 5,635 | 84,911 | 2,565 |
| 30 Sep 19 | 837,742 | 1,596 | 80,955 | 1,877 |
| 30 Jun 19 | 831,002 | -3,418 | 80,198 | 1,977 |
| 31 Mar 19 | 818,057 | -6,049 | 79,471 | 2,043 |
| 31 Dec 18 | 813,073 | -3,219 | 77,302 | 1,744 |
| 30 Sep 18 | 792,837 | 1,523 | 77,935 | 1,351 |
| 30 Jun 18 | 788,921 | 9,569 | 78,612 | 1,528 |
| 31 Mar 18 | 806,266 | 9,201 | 78,926 | 1,521 |
| 31 Dec 17 | 827,336 | 9,813 | 79,092 | 1,453 |
| 30 Sep 17 | 850,580 | 20,190 | 81,376 | 1,955 |
| 30 Jun 17 | 839,401 | 22,089 | 80,801 | 1,611 |
| 31 Mar 17 | 841,381 | 32,253 | 82,399 | 1,583 |
| 31 Dec 16 | 852,913 | 37,469 | 82,558 | 1,698 |
| 30 Sep 16 | 853,514 | 30,534 | 83,599 | 1,364 |
| 30 Jun 16 | 890,103 | 30,945 | 76,823 | 1,409 |
| 31 Mar 16 | 901,650 | 25,859 | 76,091 | 1,325 |
| 31 Dec 15 | 871,225 | 20,288 | 76,261 | 1,243 |
| 30 Sep 15 | 920,032 | 16,559 | 75,493 | 1,926 |
| 30 Jun 15 | 898,011 | 11,686 | 81,087 | 1,647 |
| 31 Mar 15 | 887,272 | 9,572 | 77,688 | 1,480 |
| 31 Dec 14 | 905,441 | 7,282 | 75,989 | 1,216 |
| 30 Sep 14 | 848,663 | 13,280 | 67,782 | 403 |
| 30 Jun 14 | 860,799 | 8,321 | 67,096 | 361 |
| 31 Mar 14 | 848,759 | 1,719 | 66,962 | 390 |
| 31 Dec 13 | 823,410 | 599 | 66,299 | 427 |
| 30 Sep 13 | 784,436 | 3,581 | 63,063 | 323 |
| 30 Jun 13 | 748,196 | 10,195 | 63,614 | 251 |
Quality Earnings: A102260 has high quality earnings.
Growing Profit Margin: A102260's current net profit margins (3%) are lower than last year (3.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A102260 has become profitable over the past 5 years, growing earnings by 52.5% per year.
Accelerating Growth: A102260's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A102260 had negative earnings growth (-4.5%) over the past year, making it difficult to compare to the Chemicals industry average (-17.6%).
Return on Equity
High ROE: A102260's Return on Equity (11.2%) is considered low.